Head and Neck Squamous Cell Carcinoma Clinical Trials in Beijing, Beijing Municipality
7 recruitingBeijing, Beijing Municipality, China
Showing 1–7 of 7 trials
Recruiting
Phase 2
Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China
Head and Neck Squamous Cell Carcinoma
Yuankai Shi150 enrolled1 locationNCT04857164
Recruiting
Phase 2
Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC
Head and Neck Squamous Cell Carcinoma
Beijing Tongren Hospital50 enrolled1 locationNCT06725498
Recruiting
Phase 2
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Head and Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D Company170 enrolled25 locationsNCT06007729
Recruiting
Phase 2
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
Head and Neck Squamous Cell Carcinoma
Beijing Tongren Hospital100 enrolled1 locationNCT06100497
Recruiting
Phase 2
A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)
Head and Neck Squamous Cell Carcinoma
Lyvgen Biopharma Holdings Limited64 enrolled17 locationsNCT06378177
Recruiting
Phase 2
Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC
Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences173 enrolled1 locationNCT06170710
Recruiting
Phase 3
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Neoadjuvant TherapyHead and Neck Squamous Cell CarcinomaPembrolizumab
Beijing Tongren Hospital272 enrolled1 locationNCT06102395